Loading...
OTCM
FREHY
Market cap826kUSD
Jun 09, Last price  
0.02USD
1Q
-80.00%
IPO
-96.67%
Name

Anpac Bio Medical Science Co Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
3.31
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-29.78%
Rev. gr., 5y
16.20%
Revenues
2m
-35.86%
841,3451,549,0371,569,4972,971,3562,788,8041,788,611
Net income
-15m
L-17.78%
-5,781,994-6,356,797-14,625,488-11,659,267-18,404,156-15,131,768
CFO
-8m
L-26.46%
-3,202,173-4,707,109-7,033,433-8,543,175-11,118,780-8,176,765

Profile

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
URL
http://www.anpac.cn/
IPO date
Jan 30, 2020
Employees
89
Domiciled in
CN
Incorporated in
VG

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
1,789
-35.86%
Cost of revenue
85,725
Unusual Expense (Income)
NOPBT
(83,936)
NOPBT Margin
Operating Taxes
(316)
Tax Rate
NOPAT
(83,620)
Net income
(15,132)
-17.78%
Dividends
Dividend yield
Proceeds from repurchase of equity
7,433
BB yield
Debt
Debt current
834
Long-term debt
7,452
Deferred revenue
Other long-term liabilities
(5,422)
Net debt
7,862
Cash flow
Cash from operating activities
(8,177)
CAPEX
(236)
Cash from investing activities
(236)
Cash from financing activities
7,346
FCF
(81,551)
Balance
Cash
269
Long term investments
155
Excess cash
335
Stockholders' equity
(81,026)
Invested Capital
81,241
ROIC
ROCE
EV
Common stock shares outstanding
191
Price
Market cap
EV
EBITDA
(83,120)
EV/EBITDA
Interest
373
Interest/NOPBT